Truist Financial Remains a Buy on Veeva Systems (VEEV)
Truist Financial analyst Jailendra Singh reiterated a Buy rating on Veeva Systems today and set a price target of $262.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Singh is an analyst with an average return of -15.2% and a 32.28% success rate. Singh covers the Healthcare sector, focusing on stocks such as IQVIA Holdings, Hims & Hers Health, and Hinge Health, Inc. Class A.
In addition to Truist Financial, Veeva Systems also received a Buy from Barclays’s Saket Kalia in a report issued today. However, on the same day, TipRanks – Anthropic downgraded Veeva Systems (NYSE: VEEV) to a Hold.
Based on Veeva Systems’ latest earnings release for the quarter ending January 31, the company reported a quarterly revenue of $835.95 million and a net profit of $244.2 million. In comparison, last year the company earned a revenue of $720.89 million and had a net profit of $195.63 million
Read More on VEEV:
Disclaimer & DisclosureReport an Issue
- Veeva price target raised to $215 from $205 at Morgan Stanley
- Veeva price target raised to $245 from $212 at Stifel
- Veeva price target raised to $235 from $200 at Canaccord
- Strong Near-Term Execution but Uncertain Long-Term Growth Drivers Justify Hold on Veeva
- Veeva price target lowered to $317 from $333 at Wells Fargo
